137 related articles for article (PubMed ID: 332349)
21. Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Pouillart P; Hayat M; Schwarzenberg L; Amiel JL; Mathé G; Tubiana M
Br J Cancer Suppl; 1975 Mar; 2():505-11. PubMed ID: 52369
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
[TBL] [Abstract][Full Text] [Related]
23. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
24. The influence of chemotherapy on the management of non-Hodgkin's lymphomata at the Princess Margaret Hospital. A comparison of the results from 1962-64 with 1967-69.
Bergsagel DE; Brown TC; Reid J
Br J Cancer Suppl; 1975 Mar; 2():489-96. PubMed ID: 1101934
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
26. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
27. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].
Su ZY; Zhang DS; Zhu MQ; Shi YX; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):919-22. PubMed ID: 17697560
[TBL] [Abstract][Full Text] [Related]
28. Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
Klener P; Donner L
Neoplasma; 1975; 22(1):55-62. PubMed ID: 1097949
[TBL] [Abstract][Full Text] [Related]
29. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
[TBL] [Abstract][Full Text] [Related]
30. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factors of invasive non-Hodgkin's lymphoma].
Yu H; Hong XN; Li J; Peng LP; Ye L
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
[TBL] [Abstract][Full Text] [Related]
32. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Nissen NI; Pajak T; Glidewell O; Blom H; Flaherty M; Hayes D; McIntyre R; Holland JF
Cancer Treat Rep; 1977 Sep; 61(6):1097-107. PubMed ID: 71208
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
Li YH; Jiang WQ; Huang HQ; Xu RH; Lin TY; Xia ZJ; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):401-3. PubMed ID: 12703998
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Coltman CA; Luce JK; McKelvey EM; Jones SE; Moon TE
Cancer Treat Rep; 1977 Sep; 61(6):1067-78. PubMed ID: 71206
[TBL] [Abstract][Full Text] [Related]
35. Team approach to management of non-Hodgkin's lymphomas: past and present.
Fuller LM; Gamble JF; Butler JJ; Sinkovics JG; Wallace S; Martin RG; Gehan EA; Shullenberger CC
Cancer Treat Rep; 1977 Sep; 61(6):1137-48. PubMed ID: 71210
[TBL] [Abstract][Full Text] [Related]
36. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
[TBL] [Abstract][Full Text] [Related]
37. [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].
Tigges FJ; Schmülling RM; Hiller E; Waller HD; Wilms K
Dtsch Med Wochenschr; 1977 Oct; 102(43):1537-41. PubMed ID: 334504
[TBL] [Abstract][Full Text] [Related]
38. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
[TBL] [Abstract][Full Text] [Related]
39. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Durant JR; Loeb V; Dorfman R; Chan YK
Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
[TBL] [Abstract][Full Text] [Related]
40. A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma.
Brereton HD; Young RC; Longo DL; Kirkland LR; Berard CW; Jaffe ES; DeVita VT; Johnson RE
Cancer; 1979 Jun; 43(6):2227-31. PubMed ID: 378350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
